{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:35:02Z","timestamp":1793439302489,"version":"4.5.0"},"reference-count":44,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2021,5,18]]},"abstract":"<jats:p>We previously reported that recombinant Newcastle disease virus LaSota (rLS) expressing infectious bronchitis virus (IBV) Arkansas (Ark)-type trimeric spike (S) ectodomain (Se; rLS\/ArkSe) provides suboptimal protection against IBV challenge. We have now developed rLS expressing chicken granulocyte-macrophage colony-stimulating factor (GMCSF) and IBV Ark Se in an attempt to enhance vaccine effectiveness. In the current study, we first compared protection conferred by vaccination with rLS\/ArkSe and rLS\/ArkSe.GMCSF. Vaccinated chickens were challenged with virulent Ark, and protection was determined by clinical signs, viral load, and tracheal histomorphometry. Results showed that coexpression of GMCSF and the Se from rLS significantly reduced tracheal viral load and tracheal lesions compared with chickens vaccinated with rLS\/ArkSe. In a second experiment, we evaluated enhancement of cross-protection of a Massachusetts (Mass) attenuated vaccine by priming or boosting with rLS\/ArkSe.GMCSF. Vaccinated chickens were challenged with Ark, and protection was evaluated. Results show that priming or boosting with the recombinant virus significantly increased cross-protection conferred by Mass against Ark virulent challenge. Greater reductions of viral loads in both trachea and lachrymal fluids were observed in chickens primed with rLS\/ArkSe.GMCSF and boosted with Mass. Consistently, Ark Se antibody levels measured with recombinant Ark Se protein\u2013coated ELISA plates 14 days after boost were significantly higher in these chickens. Unexpectedly, the inverse vaccination scheme, that is, priming with Mass and boosting with the recombinant vaccine, proved somewhat less effective. We concluded that a prime and boost strategy by using rLS\/ArkSe.GMCSF and the worldwide ubiquitous Mass attenuated vaccine provides enhanced cross-protection. Thus, rLS\/GMCSF coexpressing the Se of regionally relevant IBV serotypes could be used in combination with live Mass to protect against regionally circulating IBV variant strains.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-21-00032","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T08:23:33Z","timestamp":1627460613000},"page":"364-372","source":"Crossref","is-referenced-by-count":9,"title":["Enhanced Protection by Recombinant Newcastle Disease Virus Expressing Infectious Bronchitis Virus Spike Ectodomain and Chicken Granulocyte-Macrophage Colony-Stimulating Factor"],"prefix":"10.1637","volume":"65","author":[{"given":"Z.","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Breedlove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Joiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"RA Gallardo, VL van Santen, H Toro,  \"Avian Dis.\"  54, \"Host intraspatial selection of infectious bronchitis virus populations.\" 807 (2010)","DOI":"10.1637\/9054-090809-Reg.1"},{"key":"1","doi-asserted-by":"crossref","unstructured":"H Toro, MW Jackwood, VL van Santen,  \"Avian Dis.\"  56, \"Genetic diversity and selection regulates evolution of infectious bronchitis virus.\" 449 (2012)","DOI":"10.1637\/10072-020212-Review.1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"ET McKinley, DA Hilt, MW Jackwood,  \"Vaccine.\"  26, \"Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination.\" 1274 (2008)","DOI":"10.1016\/j.vaccine.2008.01.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"VL van Santen  and H Toro  \"Avian Pathol.\"  37, \"Rapid selection in chickens of subpopulations within ArkDPI-derived infectious bronchitis virus vaccines.\" 293 (2008)","DOI":"10.1080\/03079450802043783"},{"key":"5","doi-asserted-by":"crossref","unstructured":"MW Jackwood  and DH Lee  \"PLoS One.\"  12, \"Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry.\" e0176709 (2017)","DOI":"10.1371\/journal.pone.0176709"},{"key":"6","doi-asserted-by":"crossref","unstructured":"AM Ghetas, GE Thaxton, C Breedlove, et al.  \"Avian Dis.\"  59, \"Effects of adaptation of infectious bronchitis virus Arkansas attenuated vaccine to embryonic kidney cells.\" 106 (2015)","DOI":"10.1637\/10947-093014-Reg"},{"key":"8","doi-asserted-by":"crossref","unstructured":"RA Zegpi, S Gulley, VL van Santen, et al.  \"Avian Dis.\"  63, \"Infectious bronchitis virus vaccination at day one of age further limits cross-protection.\" 302 (2019)","DOI":"10.1637\/12009-120518-Reg.1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"H Toro, JF Zhang, RA Gallardo, et al.  \"Avian Dis.\"  58, \"S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge.\" 211 (2014)","DOI":"10.1637\/10670-091913"},{"key":"10","doi-asserted-by":"crossref","unstructured":"H Toro, W Zhao, C Breedlove, et al.  \"Avian Dis.\"  58, \"Infectious bronchitis virus S2 expressed from recombinant virus confers broad protection against challenge.\" 83 (2014)","DOI":"10.1637\/10641-081613-Reg.1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Q Yu, JP Roth, H Hu, et al.  \"World J Vaccines.\"  3, \"Protection by recombinant Newcastle disease viruses (NDV) expressing the glycoprotein (G) of avian metapneumovirus (aMPV) subtype A or B against challenge with virulent NDV and aMPV.\" 130 (2013)","DOI":"10.4236\/wjv.2013.34018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"E Shirvani, A Paldurai, VK Manoharan, et al.  \"Sci Rep.\"  8, \"A recombinant Newcastle disease virus (NDV) expressing S protein of infectious bronchitis virus (IBV) protects chickens against IBV and NDV.\" 11951 (2018)","DOI":"10.1038\/s41598-018-30356-2"},{"key":"30","doi-asserted-by":"crossref","unstructured":"RA Gallardo, FJ Hoerr, WD Berry, et al.  \"Avian Dis.\"  55, \"Infectious bronchitis virus in testicles and venereal transmission.\" 255 (2011)","DOI":"10.1637\/9592-102910-Reg.1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"H Toro, VL van Santen, L Li, et al.  \"Avian Pathol.\"  35, \"Epidemiological and experimental evidence for immunodeficiency affecting avian infectious bronchitis.\" 1 (2006)","DOI":"10.1080\/03079450601028811"},{"key":"32","doi-asserted-by":"crossref","unstructured":"AM Ghetas, VL van Santen, K Joiner, et al.  \"Avian Dis.\"  60, \"Kidney cell-adapted infectious bronchitis ArkDPI vaccine confers effective protection against challenge.\" 418 (2016)","DOI":"10.1637\/11291-093015-Reg"},{"key":"36","doi-asserted-by":"crossref","unstructured":"H Hu, J Roth, CN Estevez, et al.  \"Vaccine.\"  29, \"Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys.\" 8624 (2011)","DOI":"10.1016\/j.vaccine.2011.09.007"},{"key":"40","doi-asserted-by":"publisher","unstructured":"SA Callison, DA Hilt, TO Boynton, et al.  \"J Virol Methods.\"  138, \"Development and evaluation of a real-time Taqman rt-PCR assay for the detection of infectious bronchitis virus from infected chickens.\" 60 (2006)","DOI":"10.1016\/j.jviromet.2006.07.018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"H Toro, D Pennington, RA Gallardo, et al.  \"Avian Dis.\"  56, \"Infectious bronchitis virus subpopulations in vaccinated chickens after challenge.\" 501 (2012)","DOI":"10.1637\/9982-110811-Reg.1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"W Zhao, S Spatz, Z Zhang, et al.  \"J Virol.\"  88, \"Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.\" 8397 (2014)","DOI":"10.1128\/JVI.01321-14"},{"key":"11","doi-asserted-by":"crossref","unstructured":"F Eldemery, Y Li, Q Yu, et al.  \"Avian Dis.\"  61, \"Infectious bronchitis virus S2 of 4\/91 expressed from recombinant virus does not protect against Ark-type challenge.\" 397 (2017)","DOI":"10.1637\/11632-032017-ResNoteR"},{"key":"14","doi-asserted-by":"crossref","unstructured":"RA Zegpi, L He, Q Yu, et al.  \"Avian Dis.\"  64, \"Limited protection conferred by recombinant Newcastle disease virus expressing infectious bronchitis spike protein.\" 53 (2020)","DOI":"10.1637\/0005-2086-64.1.53"},{"key":"17","doi-asserted-by":"crossref","unstructured":"YH Chow, BL Chiang, YL Lee, et al.  \"J Immunol.\"  160, \"Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.\" 1320 (1998)","DOI":"10.4049\/jimmunol.160.3.1320"},{"key":"18","doi-asserted-by":"crossref","unstructured":"YJ Du, P Jiang, YF Li, et al.  \"Vaccine.\"  25, \"Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.\" 8209 (2007)","DOI":"10.1016\/j.vaccine.2007.09.062"},{"key":"19","doi-asserted-by":"crossref","unstructured":"MK Hsieh, CC Wu, TL Lin,  \"Vaccine.\"  24, \"The effect of co-administration of DNA carrying chicken interferon-\u03b3 gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination.\" 6955 (2006)","DOI":"10.1016\/j.vaccine.2006.05.127"},{"key":"20","doi-asserted-by":"crossref","unstructured":"C Heufler, F Koch, G Schuler,  \"J Exp Med.\"  167, \"Granulocyte\/macrophage colonystimulating factor and interleukin 1 mediate the maturation of murine epidermal langerhans cells into potent immunostimulatory dendritic cells.\" 700 (1988)","DOI":"10.1084\/jem.167.2.700"},{"key":"21","doi-asserted-by":"crossref","unstructured":"DL Foss, AM Bennaars, CA Pennell, et al.  \"Vet Immunol Immunopathol.\"  91, \"Differentiation of porcine dendritic cells by granulocyte-macrophage colony-stimulating factor expressed in Pichia pastoris.\" 205 (2003)","DOI":"10.1016\/S0165-2427(03)00002-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"K Inaba, M Inaba, N Romani, et al.  \"J Exp Med.\"  176, \"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor.\" 1693 (1992)","DOI":"10.1084\/jem.176.6.1693"},{"key":"23","doi-asserted-by":"crossref","unstructured":"YF Shi, CH Liu, AI Roberts, et al.  \"Cell Res.\"  16, \"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know.\" 126 (2006)","DOI":"10.1038\/sj.cr.7310017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"A Tazi, F Bouchonnet, M Grandsaigne, et al.  \"J Clin Invest.\"  91, \"Evidence that granulocyte macrophage-colony stimulating factor regulates the distribution and differentiated state of dendritic cells\/Langerhans cells in human lung and lung cancers.\" 566 (1993)","DOI":"10.1172\/JCI116236"},{"key":"25","doi-asserted-by":"crossref","unstructured":"M Andrew, K Morris, B Coupar, et al.  \"Vaccine.\"  24, \"Porcine interleukin-3 enhances DNA vaccination against classical swine fever.\" 3241 (2006)","DOI":"10.1016\/j.vaccine.2006.01.023"},{"key":"26","doi-asserted-by":"crossref","unstructured":"JN Parker, LA Pfister, D Quenelle, et al.  \"Vaccine.\"  24, \"Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates.\" 1644 (2006)","DOI":"10.1016\/j.vaccine.2005.09.051"},{"key":"27","doi-asserted-by":"crossref","unstructured":"B Tan, H Wang, L Shang, et al.  \"Arch Virol.\"  154, \"Coadministration of chicken GM-CSF with a DNA vaccine expressing infectious bronchitis virus (IBV) S1 glycoprotein enhances the specific immune response and protects against IBV infection.\" 1117 (2009)","DOI":"10.1007\/s00705-009-0424-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"B Zeshan, MH Mushtaq, X Wang, et al.  \"Vet Microbiol.\"  148, \"Protective immune responses induced by in ovo immunization with recombinant adenoviruses expressing spike (S1) glycoprotein of infectious bronchitis virus fused\/co-administered with granulocyte-macrophage colony stimulating factor.\" 8 (2011)","DOI":"10.1016\/j.vetmic.2010.08.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"L He, Z Zhang, Q Yu,  \"Front Microbiol.\"  11, \"Expression of two foreign genes by a Newcastle disease virus vector from the optimal insertion sites through a combination of the ITU and IRES-dependent expression approaches.\" 769 (2020)","DOI":"10.3389\/fmicb.2020.00769"},{"key":"34","doi-asserted-by":"crossref","unstructured":"C Estevez, D King, B Seal, et al.  \"Virus Res.\"  129, \"Evaluation of Newcastle disease virus chimeras expressing the hemagglutinin-neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone.\" 182 (2007)","DOI":"10.1016\/j.virusres.2007.07.008"},{"key":"37","doi-asserted-by":"crossref","unstructured":"RA Zegpi, C Breedlove, S Gulley, et al.  \"Avian Dis.\"  64, \"Infectious bronchitis virus immune responses in the Harderian gland upon initial vaccination\" 92 (2020)","DOI":"10.1637\/0005-2086-64.1.92"},{"key":"38","doi-asserted-by":"crossref","unstructured":"RA Zegpi, KS Joiner, V van Santen, et al.  \"Avian Dis.\"  64, \"Infectious bronchitis virus population structure defines immune response and protection.\" 60 (2020)","DOI":"10.1637\/0005-2086-64.1.60"},{"key":"42","doi-asserted-by":"crossref","unstructured":"K Bertran, D-H Lee, MF Criado, et al.  \"Vaccine.\"  36, \"Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.\" 6361 (2018)","DOI":"10.1016\/j.vaccine.2018.09.015"},{"key":"43","doi-asserted-by":"crossref","unstructured":"M Murr, C Grund, A Breithaupt, et al.  \"Avian Dis.\"  64, \"Protection of chickens with maternal immunity against avian influenza virus (AIV) by vaccination with a novel recombinant Newcastle disease virus vector.\" 427 (2020)","DOI":"10.1637\/aviandiseases-D-20-00014"},{"key":"44","doi-asserted-by":"crossref","unstructured":"MW Jackwood, DA Hilt, CW Lee, et al.  \"Avian Dis.\"  49, \"Data from 11 years of molecular typing infectious bronchitis virus field isolates.\" 614 (2005)","DOI":"10.1637\/7389-052905R.1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"HH Abozeid, A Paldurai, BP Varghese, et al.  \"Vet Res.\"  50, \"Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt.\" (2019)","DOI":"10.1186\/s13567-019-0631-5"},{"key":"31","unstructured":"P. Villegas,  \"A laboratory manual for the isolation, identification and characterization of avian pathogens.\"  \"Titration of biological suspensions.\" 355 (2016)"},{"key":"35","unstructured":"DJ Alexander  and DA Senne  \"A laboratory manual for the isolation, identification and characterization of avian pathogens.\"  \"Newcastle disease virus and other avian paramyxoviruses.\" 135 (2008)"},{"key":"39","unstructured":"PS Wackenell, SG Thayer, CW Beard,  \"A laboratory manual for the isolation and identification, and characterization of avian pathogens.\"  \"Serologic procedures.\" 343 (2016)"},{"key":"41","unstructured":"\"ImageJ, Bethesda (MD).\""}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-65\/issue-3\/aviandiseases-D-21-00032\/Enhanced-Protection-by-Recombinant-Newcastle-Disease-Virus-Expressing-Infectious-Bronchitis\/10.1637\/aviandiseases-D-21-00032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:13:46Z","timestamp":1793438026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-65\/issue-3\/aviandiseases-D-21-00032\/Enhanced-Protection-by-Recombinant-Newcastle-Disease-Virus-Expressing-Infectious-Bronchitis\/10.1637\/aviandiseases-D-21-00032.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-21-00032","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}